SPHERITECH - Key Persons
Job Titles:
- Member of the Scientific Advisory Board
- Chairman of the SAB
Dr Brian Adger the chairman of the SAB is a consultant with over 30 years industrial experience within the pharmaceutical, biotechnology and fine chemical sectors working with companies including Smith Kline French (now GSK), Sterling Organics, Great Lakes Chemical Europe and Chiroscience in senior research and development positions. He started a consultancy business in 1997, providing expertise in complex organic synthesis and chiral technologies and is chairman of the SAB of Johnson Matthey Catalysis and a Fellow of the Royal Society of Chemistry.
Don Wellings is an internationally recognised authority on peptide synthesis, polymer design, and chromatography with over 30 years' experience of working in major organisations having held senior scientific posts in ICI, Zeneca, Avecia, and Polymer Laboratories. Prior to founding SpheriTech he founded Chromatide where he worked as Chief Scientific Officer for 3 years and was credited as the sole inventor of all of the Company's intellectual property.
With a track record of innovation, he is the main inventor on 19 patents and the sole inventor on all patents filed by SpheriTech to date.
As the founder and Managing Director of SpheriTech Ltd and as the principal in a SME, Don leads on all scientific, managerial and operational matters. In this endeavour he is supported by a small highly experienced group of scientists who have worked with him for many years both in SpheriTech and other companies.
Don Wellings, the founder of SpheriTech has more than 40 years industrial experience gained from working in blue chip companies.
Job Titles:
- Consultant
- Member of the Scientific Advisory Board
Dr Eric Atherton is a consultant with over 30 years experience in peptide chemistry, who together with Dr Bob Sheppard, developed Fmoc-solid phase peptide synthesis methodologies which have revolutionized the solid phase manufacture of peptides. Eric was a senior scientist at the Laboratory of Molecular Biology from 1972 to 1985 before joining CRB as Technology Director. He has also held senior management positions at Avecia, Zeneca and ICI and currently acts as a peptide synthesis consultant.
Job Titles:
- Member of the Scientific Advisory Board
- Scientist
Dr Ian M Varndell: Scientist, entrepreneur, businessman and investor with 40 years' experience within the life science industry and academia.
Dr Ian Varndell is a biologist with 40 years experience of developing and manufacturing life science research products. In 1983 he was appointed Lecturer in Histochemistry at the Royal Postgraduate Medical School in London (now part of Imperial College's Hammersmith campus), and later joined Cambridge Research Biochemicals (CRB) to work within the Contract Research Group. After CRB's acquisition by ICI Biological Products he formed Affiniti Research Products Ltd in 1991, and co-founded BIOMOL International LP in 2004 which was itself acquired by Enzo Life Sciences in 2008. Ian has published almost 60 scientific papers and book chapters, and holds several UK directorships. He is a Fellow of the Society of Biology.
Job Titles:
- Scientist, Entrepreneur, Businessman and Investor With Some 40 Years' Experience Within the Life Science Industry
Dr Eric Atherton is a consultant with over 30 years experience in peptide chemistry, who together with Dr Bob Sheppard, developed Fmoc-solid phase peptide synthesis methodologies which have revolutionized the solid phase manufacture of peptides. Eric was a senior scientist at the Laboratory of Molecular Biology from 1972 to 1985 before joining CRB as Technology Director. He has also held senior management positions at Avecia, Zeneca and ICI and currently acts as a peptide synthesis consultant.
Dr Paul W Sheppard, NED: Scientist, entrepreneur, businessman and investor with some 40 years' experience within the life science industry.
Job Titles:
- Director of Business Development ( Part - Time )
Mr Chris Harris, Director of Business Development (part-time): Former healthcare professional with over 35 years' senior management experience in the medical device industry; an advocate of health technology innovation, especially in relation to start-up and early stage businesses in the life science sector.
Job Titles:
- Patent Attorney With Bawden and Associates
The SpheriTech management team is supported by a panel of professional advisors drawn from both academia, healthcare and life science industry.
The company has a vast network of contacts in both academia and industry providing access to a broad range of specialist expertise. The current Scientific Advisory Board is comprised of individuals highly respected for their contributions to the industry.